Genenta Science - רווח נקי למניה ב-12 החודשים האחרונים GNTA

This chart of the current share price for Genenta Science S.p.A. (GNTA) demonstrates an EPS of 29.50. Genenta Science S.p.A. (GNTA) specializes in developing innovative methods to combat glioblastoma, leveraging massive demand within neuro-oncology. Its success is based on the use of lentiviral vectors for the targeted delivery of drugs to the site of the disease. The firm's strategy is aimed at expanding research and capturing the global market for solid tumor therapy.
פילוחי מדדים פיננסיים ומדדי שוק עבור Genenta Science (GNTA)

This metric assesses the dynamics of net profit per share over the last twelve months, reflecting the efficiency of profit capitalization and the resilience of the operating model. For Genenta Science (GNTA), which is developing unique cancer immunotherapy, the annual EPS growth based on financial statements (TTM) demonstrates the company's ability to convert innovation into tangible financial results amid its expansion in the B2B segment.